Study on the Adverse Drug Reactions (ADRs) of Apatinib and Their Biomarker Correlations

NCT03475589 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

217

Enrollment

OTHER

Sponsor class

Conditions

Stage IV Cancer

Interventions

DRUG: apatinib

Sponsor

Sun Yat-sen University